I strongly believe getting the license to mine and environmental signoff is the big ticket item. Finance will come soon after. There's too many big name connections for this to stall any longer once the NT gives TNG the go ahead.
Vanadium is going to be a strategic metal for large material firms, and Australia's relatively low sovereign risk makes the company quite appealing. High labour costs yes, but it will succeed with the scale that TNG offers.
Could be a real bolter of a stock over the next 24 months, but like many here believe the Browns have made the right move to make sure the board delivers. Whilst this week's rush of news is encouraging this is not a time for the BoD to be complacent. This is their chance to remembered as the developers of an FMG style play rather than a CDU style shipwreck. Both of those boards will be remembered forever and a day for their respective grand success and catastrophic embarrassment to the Aussie mining industry.
- Forums
- ASX - By Stock
- TVN
- TNG appoints German giant for vanadium study
TNG appoints German giant for vanadium study, page-5
-
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TVN (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $98.20M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.7¢ | $60.52K | 1.032M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 655737 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 8153 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 655737 | 0.057 |
6 | 555883 | 0.056 |
4 | 363234 | 0.055 |
2 | 143425 | 0.054 |
1 | 100000 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 8153 | 1 |
0.060 | 64474 | 2 |
0.062 | 228000 | 2 |
0.063 | 100000 | 1 |
0.064 | 175201 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
TVN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online